🌐EnglishEnglishDeutschEspañolFrançaisРусскийالعربية中文日本語EntityQ25324636· pop 10· linked from 35 articlesproteolysis targeting chimeraAlso known as PROTAC, PROTACssmall moleculeResearch1,493 papersPreclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader.Molecular cancer therapeutics · 2025Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets.Journal of the American Chemical Society · 2022PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.Targeted oncology · 2025Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors.Communications biology · 2024Proteolysis Targeting Chimera (PROTACs) in Cancer: From Molecular Mechanisms to Therapeutic Opportunities.Journal of biochemical and molecular toxicology · 2025via PubMedWikidata factsImageHow PROTACs Use Our Cells' Natural Disposal System to Kill Cancer-Causing Proteins.jpgAvailable in 9 languagesEspañolFrançaisDeutsch中文日本語РусскийالعربيةEstonianvia Wikidata sitelinks · CC0Connectionsdigital object identifierEntityYale UniversityEntityCategoriesBiotechnologyChemical biologyPharmacologyProteolysis targeting chimeras